Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
pharmaceutical-investing Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
pharmaceutical-investing Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study
pharmaceutical-investing Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
pharmaceutical-investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
Sun Summit Confirms the High-Grade Gold-Silver Potential of the Finn Zone: Drills 5.30 g/t Gold and 157.9 g/t Silver over 6.0 meters at the JD Project
Argenta Silver Announces Closing of Bought Deal LIFE Private Placement for Gross Proceeds of C$23 Million